Zifo Technologies has launched its Antibody Engineering application, a cloud-native generative AI platform on the Snowflake Data Cloud, designed to accelerate biologics and drug discovery. Available on the Snowflake Marketplace, this solution empowers biopharma companies, research institutions, and contract research organizations to streamline therapeutic antibody design while maintaining data security within Snowflake’s ecosystem.
Zifo’s Antibody Engineering app enhances biologics discovery on Snowflake Marketplace.
Integrates AI models like ProtGPT2, ESM, and RoBERTa for flexible antibody design.
Reduces drug discovery timelines with an end-to-end AI-driven workflow.
No-code interface allows scientists to fine-tune models on proprietary datasets.
Ensures data security by keeping sensitive information within Snowflake’s environment.
Supports biopharma, CROs, and research institutions in optimizing antibody development.
Zifo’s Antibody Engineering application addresses the traditionally complex and costly process of developing antibody-based therapies. By leveraging three open-source AI models—ProtGPT2, ESM, and RoBERTa—the platform offers flexibility, allowing users to benchmark and tailor models within a single environment. This eliminates the challenges of model selection and accelerates the discovery pipeline, from generating novel antibody sequences to predicting 3D structures. “We are entering a new era of drug discovery, one where AI and data converge to solve biology’s most complex puzzles,” said Chris McClure, Head of Solution Services for Zifo in North America.
Built on the Snowflake Data Cloud and utilizing Snowpark Container Services, the application provides a no-code, intuitive interface for scientists and bioinformaticians. Users can fine-tune protein language models on proprietary datasets without moving sensitive data outside Snowflake’s secure environment, ensuring compliance and data sovereignty. “Zifo Antibody Engineering, combined with Snowflake’s infrastructure, offers life sciences a cutting-edge tool for research development,” said Lisa Arbogast, Industry Principal for Healthcare and Life Sciences Ecosystem at Snowflake. “Together, we enable use of data to its fullest potential while helping customers adhere to high standards of security and compliance.”
The platform streamlines the entire antibody discovery process, improving the hit rate for high-affinity therapeutic antibodies. Its cloud-native, scalable architecture allows researchers to move from input to insight within a single integrated platform, reducing R&D costs and timelines. “Zifo Antibody Engineering is more than just a tool; it’s a strategic partner for scientists. By building it as a Snowflake Native App, we’re giving researchers the power to innovate faster, reduce R&D costs, and ultimately bring life-saving therapies to patients sooner. We’ve effectively democratized access to complex AI, removing the need for deep machine learning expertise,” McClure added.
Zifo’s application serves a wide range of life sciences stakeholders, including biopharma R&D teams, contract research organizations (CROs), and academic institutions. By enabling faster antibody sequence generation, 3D structure prediction, and key region analysis, it empowers users to push the boundaries of computational biology and structural bioinformatics. The platform’s accessibility and robust AI capabilities make it a game-changer for organizations aiming to accelerate therapeutic development while maintaining high standards of security and compliance.
Zifo’s Antibody Engineering application marks a significant advancement in AI-driven biologics discovery. By integrating state-of-the-art AI with Snowflake’s secure and scalable infrastructure, Zifo is redefining how the life sciences industry develops therapeutic antibodies, paving the way for faster, more efficient drug discovery.
Zifo is the leading global enabler of AI and data-driven enterprise informatics for science-driven organizations. With extensive solutions and services expertise spanning research, development, manufacturing, and clinical domains, we serve various industries, including pharma, biotech, chemicals, food and beverage, oil and gas, and FMCG. Trusted by over 190 science-focused organizations worldwide, Zifo is the partner of choice for advancing digital scientific innovation.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.